All the news Showing 10 of 132 articles from: TreatmentGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure Liz Highleyman / 28 November 2013 A dual regimen of entecavir (Baraclude) plus tenofovir (Viread) for 48 weeks led to virological response and was generally well-tolerated among people with chronic hepatitis B who had experienced treatment failure with ... Costs for Hepatitis C Treatment Skyrocket Medscape (requires registration) / 14 November 2013 Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk Liz Highleyman / 11 November 2013 Long-term treatment with entecavir can reduce the likelihood that people with chronic hepatitis B will develop hepatocellular carcinoma, according to findings presented last week at The Liver Meeting 2013, the 64th annual meeting ... Hepatotoxicity from herbal, dietary supplements rising Healio Hepatology / 08 November 2013 Entecavir and tenofovir both work well against hepatitis B in clinical practice Liz Highleyman / 25 October 2013 Entecavir (Baraclude) and tenofovir (Viread) both demonstrated potent activity against hepatitis B virus (HBV) in a Turkish study presented at the IDWeek 2013 conference held recently in San Francisco. Entecavir appeared to have an ... Alcoholism treatment before, after liver transplantation reduces relapse Eurekalert Medicine & Health / 07 October 2013 Liver transplant outcomes among HBV patients improved over time Healio Hepatology / 07 October 2013 Medivir and Daewoong pull plug on hepatitis B drug PharmaTimes / 06 September 2013 Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows Liz Highleyman / 03 September 2013 Tenofovir, which has potent activity against both HIV and hepatitis B virus (HBV), is the most effective hepatitis B treatment for people with HIV and HBV co-infection, according to a 23-study meta-analysis ... Besifovir noninferior to entecavir for chronic HBV in phase 2b trial Healio Hepatology / 29 August 2013 ← Prev1...910111213...14Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Transmission and prevention Diagnosis and monitoring Disease course and symptoms Treatment HIV and HBV HCV and HBV Hepatitis delta Living with HBV Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds